CN220193829U - Health care device - Google Patents
Health care device Download PDFInfo
- Publication number
- CN220193829U CN220193829U CN202320828367.7U CN202320828367U CN220193829U CN 220193829 U CN220193829 U CN 220193829U CN 202320828367 U CN202320828367 U CN 202320828367U CN 220193829 U CN220193829 U CN 220193829U
- Authority
- CN
- China
- Prior art keywords
- low
- frequency wave
- health care
- frequency
- essential oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036541 health Effects 0.000 title claims abstract description 70
- 239000000341 volatile oil Substances 0.000 claims abstract description 58
- 239000002156 adsorbate Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 31
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 description 47
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 23
- 229950006238 nadide Drugs 0.000 description 22
- 210000001744 T-lymphocyte Anatomy 0.000 description 19
- 238000001467 acupuncture Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 210000001015 abdomen Anatomy 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 239000012528 membrane Substances 0.000 description 13
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 12
- 210000000170 cell membrane Anatomy 0.000 description 12
- 210000000822 natural killer cell Anatomy 0.000 description 12
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 210000000056 organ Anatomy 0.000 description 10
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 230000036390 resting membrane potential Effects 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 210000003719 b-lymphocyte Anatomy 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 7
- 230000036982 action potential Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 150000003904 phospholipids Chemical class 0.000 description 6
- 102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 5
- 108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 5
- 239000003990 capacitor Substances 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 102000055501 telomere Human genes 0.000 description 5
- 108091035539 telomere Proteins 0.000 description 5
- 210000003411 telomere Anatomy 0.000 description 5
- 108010049140 Endorphins Proteins 0.000 description 4
- 102000009025 Endorphins Human genes 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000002102 hyperpolarization Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 3
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000010648 geranium oil Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 210000003715 limbic system Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000000196 olfactory nerve Anatomy 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 244000119308 Coleus amboinicus Species 0.000 description 1
- 235000004094 Coleus amboinicus Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000003844 DNA helicases Human genes 0.000 description 1
- 108090000133 DNA helicases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 241000378467 Melaleuca Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 244000270673 Pelargonium graveolens Species 0.000 description 1
- 235000017927 Pelargonium graveolens Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000001342 boswellia carteri birdw. oil Substances 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001111 citrus aurantium l. leaf oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000010653 helichrysum oil Substances 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001735 hyssopus officinalis l. herb oil Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003738 lymphoid progenitor cell Anatomy 0.000 description 1
- 210000005171 mammalian brain Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002336 repolarization Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 208000011317 telomere syndrome Diseases 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
Landscapes
- Percussion Or Vibration Massage (AREA)
- Medicines Containing Plant Substances (AREA)
- Massaging Devices (AREA)
Abstract
Description
技术领域Technical field
本实用新型有关于一种保健装置,特别是指一种将低频波通过植物精油载体之后再传递至人体以进行人体保健的保健装置。The utility model relates to a health care device, in particular to a health care device that transmits low-frequency waves through plant essential oil carriers to the human body for human body health care.
背景技术Background technique
目前已知的保健方式例如有刮痧、拔罐、针灸、按摩等,虽然可以达到保健的目的,但也有其缺点,例如:刮痧会使得皮肤受损,而增加感染的风险;拔罐效果与刮痧接近,但是使用上需要以罐体与皮肤接触,因此罐体的清洁与卫生堪虑;针灸,以针侵入人体所对应的穴位,因此有侵入性风险;按摩,虽然没有侵入性风险,但是却要仰赖他人帮助放松肌肉。Currently known health care methods include scraping, cupping, acupuncture, massage, etc. Although they can achieve the purpose of health care, they also have their shortcomings. For example, scraping will damage the skin and increase the risk of infection; the effect of cupping is similar to that of scraping. However, the use requires the tank to be in contact with the skin, so the cleanliness and hygiene of the tank are of concern; acupuncture uses needles to invade the corresponding acupuncture points of the human body, so there is an invasive risk; massage, although there is no invasive risk, but it requires Others help relax the muscles.
前述针灸保健方式的改良,有如微波针灸仪对人体穴位采用非侵入式辐射的保健装置,微波针灸仪采用的微波振荡器其震荡频率高达1000-2000兆赫(MHz),这很容易因为过度辐射(能量)而造成伤害。微波针灸仪也是需要对应人体穴位才能发挥功效,然而一般人却不是中医相关的专业人士,并无法精确地辨认出每个人各自的穴位,所以微波针灸仪实际上并不是可以普遍化的保健装置。The aforementioned improvement of acupuncture health care methods is like a microwave acupuncture device that uses non-invasive radiation for human acupuncture points. The microwave oscillator used by the microwave acupuncture device has an oscillation frequency as high as 1000-2000 megahertz (MHz), which is easily caused by excessive radiation ( energy) and cause damage. Microwave acupuncture instruments also need to correspond to human acupuncture points to be effective. However, most people are not professionals related to traditional Chinese medicine and cannot accurately identify each person's acupuncture points. Therefore, microwave acupuncture instruments are not actually a universal health care device.
因此,开发具有可便利操作、精确辨识使用位置,且非侵入式、非接触式、不会有过度能量风险而造成伤害的保健装置及保健方法,实为业界的趋势。Therefore, it is a trend in the industry to develop health care devices and health care methods that are easy to operate, accurately identify the use location, are non-invasive, non-contact, and do not cause harm due to excessive energy risks.
实用新型内容Utility model content
本实用新型主要是基于认知到人体主要组织器官(指的是有机体,而非人工组织或器官)具有固有的震荡频率,例如头部为8-12Hz,胸腔为4-6Hz,心脏为5Hz,腹腔为6-9Hz,血液流动频率为1.2Hz,骨头组织为1.8Hz。当人体的某一部位处于0-20Hz的低频波场域时,例如低频率的电磁波,又例如低音波或称为次声波(infrasound,其相对称呼为高于20kHz的超音波或超声波ultrasound),若其声压强度(Sound Pressure Level,单位为dB)达到一定的阈值,则会先使得位于此部位所对应的组织器官外层的弹性壁先进入振动的状态,接着这个振动会传导给组织器官的内部。特别地,当低音波的频率与组织器官的前述固有震荡频率同步时就会产生共振,此时组织器官所受到的刺激最大。当以低音波所引发的共振方式作用于组织器官时,其同时也会作用于组织器官的细胞结构例如细胞的粒线体(mitochondrion),粒线体是细胞内氧化磷酸化和合成三磷酸腺苷(ATP)的主要场所,为细胞的活动提供了化学能量,所以有「细胞的发电站」(the powerhouse of the cell)之称。The utility model is mainly based on the recognition that the main tissues and organs of the human body (referring to organisms, not artificial tissues or organs) have inherent oscillation frequencies, such as 8-12Hz for the head, 4-6Hz for the chest, and 5Hz for the heart. The abdominal cavity is 6-9Hz, the blood flow frequency is 1.2Hz, and the bone tissue is 1.8Hz. When a certain part of the human body is in the low-frequency wave field of 0-20Hz, such as low-frequency electromagnetic waves, such as bass waves or infrasound (relatively called ultrasound or ultrasonic ultrasound above 20kHz), if When the sound pressure intensity (Sound Pressure Level, unit is dB) reaches a certain threshold, the elastic wall on the outer layer of the tissue and organ corresponding to this part will first enter a state of vibration, and then this vibration will be transmitted to the tissue and organ. internal. In particular, when the frequency of the bass wave is synchronized with the aforementioned natural oscillation frequency of the tissues and organs, resonance will occur. At this time, the tissues and organs will receive the greatest stimulation. When the resonance caused by bass waves acts on tissues and organs, it will also act on the cellular structures of tissues and organs, such as the mitochondria of cells. Mitochondria are responsible for intracellular oxidative phosphorylation and synthesis of adenosine triphosphate (ATP). ) is the main place that provides chemical energy for cell activities, so it is called "the powerhouse of the cell".
ATP涉及了细胞膜的膜电位(membrane potential、transmembrane potential或membrane voltage),细胞膜是由磷脂双分子层(lipid bilayer或phospholipid bilayer)组成的薄膜,几乎所有细胞生物的细胞膜都主要由磷脂双分子层构成的,磷脂双分子层内部充满电介质,故而磷脂双分子层构成的细胞膜在电学性质上等效为一个电容器。细胞膜的结构中不只有磷脂双分子层,还有蛋白质,其中一些蛋白质扮演离子通道的角色以使得离子(例如带正电的钠离子Na+及钾离子K+)可以进行跨越细胞膜而进行运输。这种现象可以用物理学来理解,也就是说细胞膜这个电容器是一个漏电的电容器,漏电电流(离子传输)穿越了电容器。ATP involves the membrane potential (membrane potential, transmembrane potential or membrane voltage) of the cell membrane. The cell membrane is a thin film composed of a phospholipid bilayer (lipid bilayer or phospholipid bilayer). The cell membrane of almost all cellular organisms is mainly composed of a phospholipid bilayer. , the interior of the phospholipid bilayer is filled with dielectric, so the cell membrane composed of the phospholipid bilayer is equivalent to a capacitor in electrical properties. The structure of the cell membrane not only contains a phospholipid bilayer, but also proteins, some of which act as ion channels to allow ions (such as positively charged sodium ions Na + and potassium ions K + ) to be transported across the cell membrane. This phenomenon can be understood in terms of physics, which means that the capacitor of the cell membrane is a leakage capacitor, and the leakage current (ion transport) passes through the capacitor.
前述低音波所引发的共振作用也会影响腺苷酸活化蛋白酶(Adenosinemonophosphate-activated protein kinase,简称AMPK)的作用,有关于低频振动与AMPK的关系,可以参见“Low-frequency vibration promotes AMPK-mediated glucose uptakein 3T3-L1 adipocytes,D.Haba et al.,Volume7,Issue 9,September 2021”。被激活的AMPK则会使得烟硷胺磷酸核糖基转移酶(Nicotinamide phosphoribosyltransferase,简称NAMPT)增加,并且因而使得烟硷酰胺腺嘌呤二核苷酸(nicotinamide adeninedinucleotide,简称NAD+)提高,上述的关联性可以参见“AMP-activated protein kinaseregulates nicotinamide phosphoribosyl transferase expression in skeletalmuscle,J.Brandauer et al.,J Physiol.2013Oct 15;591(Pt 20):5207–5220”。再者,由于NAD+是合成ATP的关键之一,因此一旦NAD+的量提高则也会促成ATP的量也提高。The resonance caused by the aforementioned bass waves will also affect the action of Adenosinemonophosphate-activated protein kinase (AMPK). For the relationship between low-frequency vibration and AMPK, see "Low-frequency vibration promotes AMPK-mediated glucose" uptakein 3T3-L1 adipocytes,D. Haba et al., Volume 7, Issue 9, September 2021". Activated AMPK will increase nicotinamide phosphoribosyltransferase (NAMPT), and thus nicotinamide adenine dinucleotide (NAD + ). The above correlation See "AMP-activated protein kinaseregulates nicotinamide phosphoribosyl transferase expression in skeletalmuscle, J. Brandauer et al., J Physiol. 2013 Oct 15; 591 (Pt 20): 5207-5220". Furthermore, since NAD + is one of the keys to the synthesis of ATP, once the amount of NAD + increases, the amount of ATP will also increase.
另外,前述低音波所引发的共振作用于粒线体也会影响一些酶例如ATP水解酶(ATPase)与细胞膜的结合状态及酶的活性。ATPase是一个可以分解ATP以产生能量的酶,并且可以活化Na+及K+,因此又称为Na+-K+ATPase或Na+-K+泵(Na+-K+pump),Na+-K+泵可以调节细胞膜内外的钠离子与钾离子浓度而使得膜电位获得调节,例如由动作电位(actionpotential)回复到静止膜电位(resting membrane potential)。首先,细胞膜处于静止膜电位,接着静止膜电位状态的细胞膜受到适当刺激而产生的动作电位通常依序经历下列几个阶段:极化(polarization)、去极化(depolarization)、再极化(repolarization)、过极化(hyperpolarization),尤其是在过极化阶段时动作电位的膜电位会低于静止膜电位,此时必须仰赖Na+-K+泵在过极化阶段协助动作电位的膜电位回复到静止膜电位。因此,可以理解的是,长期在刺激(例如压力)下或长期人体发炎状态下,或者长期缺乏ATP及/或ATPase,则会使得细胞长期处于过极化阶段而使得膜电位会低于静止膜电位。In addition, the resonance caused by the aforementioned bass waves will also affect the binding state of some enzymes such as ATP hydrolase (ATPase) to the cell membrane and the activity of the enzyme when applied to mitochondria. ATPase is an enzyme that can decompose ATP to generate energy, and can activate Na + and K + , so it is also called Na + -K + ATPase or Na + -K + pump (Na + -K + pump), Na + - The K + pump can adjust the concentration of sodium ions and potassium ions inside and outside the cell membrane to adjust the membrane potential, such as returning from action potential to resting membrane potential. First, the cell membrane is at resting membrane potential, and then the action potential generated by appropriate stimulation of the cell membrane in the resting membrane potential state usually goes through the following stages in sequence: polarization, depolarization, and repolarization. ), hyperpolarization, especially in the hyperpolarization stage, the membrane potential of the action potential will be lower than the resting membrane potential. At this time, the Na + -K + pump must be relied on to assist the membrane potential of the action potential in the hyperpolarization stage. Return to resting membrane potential. Therefore, it is understandable that long-term exposure to stimulation (such as pressure) or long-term inflammation in the human body, or long-term lack of ATP and/or ATPase, will cause the cells to be in a hyperpolarization stage for a long time and the membrane potential will be lower than the resting membrane. Potential.
基于前述对细胞膜在电学性质上等效为电容器(或电池)的理解,膜电位就相当于电池的电压,前述过极化阶段时动作电位的膜电位会低于静止膜电位,其中过极化阶段时动作电位的膜电位可以被理解为电池于被使用后已经耗损电量后的残余电量(电压),静止膜电位则可以被对应为未被耗损电量或重新被充满电量的初始电量(电压)。据统计,人体内平均有37.2兆个细胞,也就是说人体内平均有37.2兆个“电池”。可以被理解的是,当身体长期处于压力或发炎时,细胞也是对应地长期处于过极化阶段的“电池电量耗损”状态,因此细胞无法进行或维持其应有的功能,人体组织器官也因而呈现病理现象或人呈现疲惫现象。然而,此时如果以一定强度及/或频率的低频波作用于细胞时,波的能量可被转化为热能、生物化学能和生物电能而增加了ATPase的活性,从而影响ATPase在过极化阶段协助动作电位的膜电位回复到静止膜电位,这使得对应于人体细胞的前述“电池”,由前述过极化阶段时的膜电位的“电池电量耗损”状态,回复到静止膜电位的充满电量的初始电量(电压)。换句话说,低频波可以对处于过极化阶段的细胞进行“充电”,因此以低频波作用于组织器官可以使受损的组织可以在低频波刺激下得到修复而恢复正常的功能。有关于低频波与生物体关系的例子之一,例如低频波中的极低频(Extremely Low Frequency,ELF)中的舒曼共振(Schumann Resonance)频率是7.83赫兹,恰好和哺乳动物脑的海马体的频率相同,尤其人类大脑的α波与θ波也近于8Hz,因此美国国家航空暨太空总署(NASA)在载人太空仓里装上舒曼波产生器,以维持航天员在太空中的身心健康。有关于低频波增加ATPase的活性,可以参见“Effects of low frequency magnetic fields on Na,K-ATPaseactivity,M.Blank,L.Soo,V.Papstein,Bioelectrochemistry and Bioenergetics 38(1995)267-273”,其中运用0-70Hz的低频波(磁波),使得Na+-K+ATPase的活性增加5-10%。换句话说,低频波可以使得细胞活化而对处于过极化阶段的细胞进行“充电”,因而低频波可以运用于“细胞活化技术”。在此特别说明的是,低频波也可包含电波、磁波或光波等电磁波,或者低音波。Based on the aforementioned understanding that the cell membrane is electrically equivalent to a capacitor (or battery), the membrane potential is equivalent to the voltage of the battery. During the aforementioned overpolarization stage, the membrane potential of the action potential will be lower than the resting membrane potential, in which overpolarization The membrane potential of the action potential during the phase can be understood as the residual charge (voltage) of the battery after the battery has been consumed after use. The resting membrane potential can be corresponding to the initial charge (voltage) of the battery that has not been consumed or is recharged. . According to statistics, there are an average of 37.2 trillion cells in the human body, which means there are an average of 37.2 trillion "batteries" in the human body. It can be understood that when the body is under long-term stress or inflammation, the cells are correspondingly in the "battery depletion" state of the over-polarization stage for a long time. Therefore, the cells are unable to perform or maintain their proper functions, and human tissues and organs are also damaged. Pathological phenomena occur or people experience fatigue. However, if low-frequency waves of a certain intensity and/or frequency act on cells at this time, the energy of the waves can be converted into thermal energy, biochemical energy and bioelectric energy, thereby increasing the activity of ATPase, thus affecting the overpolarization stage of ATPase. Assist the membrane potential of the action potential to return to the resting membrane potential, which allows the aforementioned "battery" corresponding to the human cell to return to the full charge of the resting membrane potential from the "battery power consumption" state of the membrane potential during the overpolarization stage. Initial power (voltage). In other words, low-frequency waves can "charge" cells in the overpolarization stage, so using low-frequency waves to act on tissues and organs can allow damaged tissues to be repaired and restore normal functions under the stimulation of low-frequency waves. There is one example of the relationship between low-frequency waves and living organisms. For example, the Schumann Resonance (Schumann Resonance) frequency in the Extremely Low Frequency (ELF) among low-frequency waves is 7.83 Hz, which is exactly the same as the hippocampus of the mammalian brain. The frequency is the same, especially the alpha and theta waves of the human brain are also close to 8Hz. Therefore, the National Aeronautics and Space Administration (NASA) installed a Schumann wave generator in the manned space capsule to maintain the physical and mental health of astronauts in space. . Regarding low frequency waves increasing the activity of ATPase, please refer to "Effects of low frequency magnetic fields on Na,K-ATPaseactivity, M. Blank, L. Soo, V. Papstein, Bioelectrochemistry and Bioenergetics 38 (1995) 267-273", where The use of low-frequency waves (magnetic waves) of 0-70Hz increases the activity of Na + -K + ATPase by 5-10%. In other words, low-frequency waves can activate cells and "charge" cells in the over-polarization stage, so low-frequency waves can be used in "cell activation technology." It should be noted here that low-frequency waves may also include electromagnetic waves such as radio waves, magnetic waves, or light waves, or bass waves.
因此可以得知,前述低音波引发了ATP及/或ATPase的量及/或活性的增加。接着,由于ATPase将ATP水解(hydrolysis)并产生能量,因此解旋酶(helicases)可以利用这些水解所产生的能量而将脱氧核糖核酸(deoxyribonucleic acid,缩写:DNA)的双股螺旋(double helix)进行DNA解旋(DNA unwinding)来解开DNA双股螺旋的结构(the doublehelix structure of the DNA),以利于DNA聚合酶(DNA Polymerase)能顺利的进行DNA复制,除了有助于细胞分裂(cell division)之外并可修复受损的基因(gene)。Therefore, it can be understood that the aforementioned bass wave causes an increase in the amount and/or activity of ATP and/or ATPase. Then, since ATPase hydrolyzes ATP and generates energy, helicases can use the energy generated by these hydrolysis to separate the double helix of deoxyribonucleic acid (DNA). Perform DNA unwinding to unwind the double helix structure of the DNA, so that DNA polymerase can successfully replicate DNA. In addition to helping cell division, division) and can repair damaged genes.
本实用新型另外认知到按照中医的理论,人体肚脐是神阙穴且是任脉、督脉、带脉、冲脉通过之处,因而当刺激神阙穴时就能够借由经络联系五脏六腑而调整全身。再者依照西医的理论,肚脐是人体腹部中表皮角质层最薄之处而且肚脐下并无脂肪组织,因此其屏障功能最弱。另外,肚脐皮肤除了一般皮肤所具有的微循环血管之外,还更具有丰富的静脉网及腹下动脉分支,因此只要对肚脐皮肤微循环血管内血液的进行某种作用或改变,就可以将此作用或改变带入人体血液循环系统中。而且,人体肚脐很容易辨识其位置也不会因人的身高胖瘦而异,因此以肚脐做为保健装置施用在人体的对应位置,则会有令使用者能够精确辨识使用位置的优势。The utility model additionally recognizes that according to the theory of traditional Chinese medicine, the human belly button is the Shenque point and is where the Ren, Du, Dai, and Chong meridians pass through. Therefore, when the Shenque point is stimulated, the internal organs can be contacted through the meridians. And adjust the whole body. Furthermore, according to the theory of Western medicine, the belly button is the thinnest part of the epidermal cuticle in the human abdomen and there is no fat tissue under the belly button, so its barrier function is the weakest. In addition, in addition to the microcirculatory blood vessels of the general skin, the navel skin also has a rich vein network and hypogastric artery branches. Therefore, as long as the blood in the microcirculatory blood vessels of the navel skin is affected or changed, it can be This effect or change is brought into the human blood circulation system. Moreover, the position of the human belly button is easy to identify and does not vary depending on the person's height or weight. Therefore, using the belly button as a health care device at the corresponding position on the human body will have the advantage of allowing users to accurately identify the location of use.
本实用新型另外认知到将可产生低频波(例如低频电波、低频磁波、低频音波)的低频波发射器以不与肚脐接触的方式,使低频波发射器朝向肚脐发射低频波以达成类似针灸的效果,则可以达到非侵入式、非接触式的保健方式。较佳地,将可产生低音波的低音波发射器以不与肚脐接触的方式,使低音波发射器朝向肚脐发射低音波以达成类似针灸的效果,则可以达到非侵入式、非接触式的保健方式,特别说明的是,本实用新型所指的低音波、低频率的音波及低频音波是相同的意思。如果直接使用低音波做为保健装置的组件,则可以避免高频率微波振荡器所产生的过度能量风险而造成伤害的问题,同时也可以避免电波或磁波对部分具有特殊体质的人所产生的不良影响。因此,上述本实用新型所达成类似针灸的效果也可称为“气灸”。The utility model also recognizes that the low-frequency wave transmitter that can generate low-frequency waves (such as low-frequency electric waves, low-frequency magnetic waves, low-frequency sound waves) is not in contact with the navel, so that the low-frequency wave emitter emits low-frequency waves toward the navel to achieve a similar effect as acupuncture. The effect can be achieved in a non-invasive and non-contact way of health care. Preferably, the bass wave transmitter that can generate bass waves is not in contact with the navel, and the bass wave transmitter emits bass waves toward the navel to achieve an effect similar to acupuncture, so that non-invasive and non-contact treatment can be achieved. In terms of health care, it should be noted that the bass waves, low-frequency sound waves and low-frequency sound waves referred to in this utility model have the same meaning. If bass waves are directly used as components of health care devices, the problem of injuries caused by excessive energy risks generated by high-frequency microwave oscillators can be avoided. At the same time, the adverse effects of radio waves or magnetic waves on some people with special physiques can also be avoided. Influence. Therefore, the above-mentioned acupuncture-like effect achieved by the present invention can also be called "qi moxibustion".
由于认知到低音波可以达成类似针灸的效果(气灸),且针灸对免疫系统的影响是针灸可以增加干扰素伽玛(Interferon gamma,γ-IFN)及神经胜肽beta-endorphin(β脑内啡)的含量而激活NK细胞(natural killer cell),NK细胞也会分泌细胞激素(cytokine),细胞激素则可以调控发炎反应。NK细胞是一种细胞质中具有大颗粒的淋巴球而为免疫细胞,是由骨髓淋巴样干细胞发育而成,主要分布于外周血(包含微循环血管内血液)和脾脏,在淋巴结和其它组织中也有少量存在。Because it is recognized that bass waves can achieve an effect similar to acupuncture (qi moxibustion), and the impact of acupuncture on the immune system is that acupuncture can increase interferon gamma (γ-IFN) and neuropeptide beta-endorphin (β-brain). The content of endorphins activates NK cells (natural killer cells). NK cells also secrete cytokines, which can regulate inflammatory responses. NK cells are lymphocytes with large granules in the cytoplasm and are immune cells. They are developed from bone marrow lymphoid stem cells and are mainly distributed in peripheral blood (including blood in microcirculatory blood vessels) and spleen, in lymph nodes and other tissues. There are also small amounts present.
基于前述「肚脐是人体腹部中表皮角质层最薄之处而且肚脐下并无脂肪组织,因此其屏障功能最弱。另外,肚脐皮肤除了一般皮肤所具有的微循环血管之外,还更具有丰富的静脉网及腹下动脉分支,因此只要对肚脐皮肤微循环血管内血液的进行某种作用或改变,就可以将此作用或改变带入人体血液循环系统中」,因此,当以低音波发射器朝向肚脐发射低音波,则会引发类似针灸的效果,使得肚脐皮肤微循环血管内血液中的γ-IFN及β脑内啡的含量会增加而激活NK细胞、B细胞(B cell、B lymphocyte)及活化T细胞(Active Tcell、Active T lymphocyte),并且因为NK细胞、B细胞及活化T细胞分泌细胞激素而可以调控发炎反应或分泌抗体。提高脑内啡的含量的方式还可以是,将前述低音波作用于装有精油(essential oil)的容器而使得容器中的精油产生搅动(可参考美国专利US6063894A或欧洲专利EP3970507A1),因此精油气味分子加速脱离容器而被传递至嗅神经并传达至大脑边缘系统,因而能提高分泌脑内啡的量而激活NK细胞、B细胞及活化T细胞。再者,精油是植物的腺体附近的细胞经光合作用所合成,因此绝大部分植物的叶子都含有精油,或者在叶子产生的精油会透过细胞壁进入腺体而存放到植物的其它部位。因此,前述低音波作用于植物也会使存放于植物中的精油散逸至空气中(可参考美国专利US3491022A有关于低音波产生反渗透reverse osmosis的影响),而被传递至嗅神经并传达至大脑边缘系统,因而能提高分泌脑内啡的量而激活NK细胞、B细胞及活化T细胞。而当前述低音波作用于含有足够水分的植物的叶子及其它部位时,则亦会如前所述产生解开DNA双股螺旋结构的效用。Based on the aforementioned "The belly button is the thinnest part of the epidermal cuticle in the human abdomen and there is no fat tissue under the belly button, so its barrier function is the weakest. In addition, in addition to the microcirculatory blood vessels that general skin has, the belly button skin is also richer in The venous network and branches of the hypogastric artery, so as long as there is some effect or change on the blood in the microcirculatory blood vessels of the navel skin, this effect or change can be brought into the human blood circulation system." Therefore, when emitting with bass waves The device emits bass waves toward the belly button, which will induce an acupuncture-like effect, increasing the content of γ-IFN and β-endorphins in the blood in the microcirculation vessels of the belly button skin and activating NK cells and B cells (B cells, B lymphocytes ) and activated T cells (Active Tcell, Active T lymphocyte), and because NK cells, B cells and activated T cells secrete cytokines, they can regulate inflammatory responses or secrete antibodies. Another way to increase the content of endorphins is to apply the aforementioned bass waves to a container containing essential oil to cause the essential oil in the container to stir (please refer to US Patent US6063894A or European Patent EP3970507A1), so that the essential oil smell The molecules accelerate out of the container and are delivered to the olfactory nerve and to the limbic system of the brain, thereby increasing the amount of endorphins secreted in the brain and activating NK cells, B cells and activated T cells. Furthermore, essential oils are synthesized by cells near the glands of plants through photosynthesis, so the leaves of most plants contain essential oils, or the essential oils produced in the leaves will enter the glands through the cell walls and be stored in other parts of the plant. Therefore, the aforementioned bass waves acting on plants will also cause the essential oils stored in the plants to dissipate into the air (please refer to US Patent No. 3491022A on the effect of bass waves on reverse osmosis), and then be transmitted to the olfactory nerve and then to the brain. Limbic system, thus increasing the secretion of endorphins and activating NK cells, B cells and activated T cells. When the aforementioned bass waves act on the leaves and other parts of plants that contain enough water, they will also have the effect of unraveling the double helix structure of DNA as mentioned above.
另外,本实用新型认知到NAD+及/或精油可以对端粒(Telomere)起保护作用,有关于精油与端粒的关联可以参考“Effects of Essential Oils on Telomere Length inHuman Cells,Plant J,Plant,Med Aromat Plants 2016,5:2),有关于NAD+与端粒的关联可以参考“NAD-Linked Metabolism and Intervention in Short Telomere Syndromesand Murine Models of Telomere Dysfunction,Amanda J Stock and Yie Liu,FrontAging.2021;2:785171”。In addition, the present invention recognizes that NAD + and/or essential oils can protect telomeres. For information on the relationship between essential oils and telomeres, please refer to "Effects of Essential Oils on Telomere Length inHuman Cells, Plant J, Plant , Med Aromat Plants 2016, 5:2), for information about the association between NAD + and telomeres, please refer to "NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction, Amanda J Stock and Yie Liu, FrontAging.2021; 2:785171".
另外,当以低音波发射器朝向肚脐发射低音波,则也会使得肚脐皮肤微循环血管内血液中的活化T细胞的Na+-K+ATPase的活性增加,所以可以使活化T细胞的活性提升;换句话说,当以低音波发射器朝向肚脐发射低音波,可以对活性低的活化T细胞进行“充电”使其恢复活性,而使得被“充电”后的活化T细胞可以重新被检验得知。所以,只要检测血液中NK细胞、B细胞或活化T细胞的含量变化即可验证本实用新型保健装置的功效;当然,也可以用NK细胞株对癌肿瘤细胞株(K562)的毒杀能力,例如以NK细胞对目标细胞比例(Effector totarget cell ratio,E/T ratio)混和培养的样品量测毒杀能力,并对结果差异性作比较,以验证本实用新型的可行性。In addition, when a bass wave emitter is used to emit bass waves toward the navel, it will also increase the Na + -K + ATPase activity of activated T cells in the blood in the microcirculation blood vessels of the navel skin, so the activity of activated T cells can be increased. In other words, when a bass wave emitter is used to emit bass waves toward the navel, activated T cells with low activity can be "charged" to restore activity, so that the "charged" activated T cells can be re-examined. Know. Therefore, the efficacy of the health care device of the present utility model can be verified by detecting changes in the content of NK cells, B cells or activated T cells in the blood; of course, the ability of the NK cell line to kill cancer cell lines (K562) can also be used. For example, the NK cell to target cell ratio (Effector to target cell ratio, E/T ratio) mixed culture sample is used to measure the killing ability, and the difference in the results is compared to verify the feasibility of the present invention.
另外,基于前述低音波引发了NAD+的量提高而促成ATP的量也提高,以及ATP及/或ATPase的量及/或活性的增加而使得DNA双股螺旋结构能够进行DNA解旋而有助于细胞分裂,所以只要检测血液中NAD+、NK细胞、B细胞或活化T细胞的含量变化即可验证本实用新型保健装置的功效。In addition, based on the aforementioned bass wave, the amount of NAD + is increased, which leads to an increase in the amount of ATP, and the increase in the amount and/or activity of ATP and/or ATPase enables the DNA double helix structure to unwind DNA and is helpful. Due to cell division, the efficacy of the health care device of the present utility model can be verified by detecting changes in the content of NAD + , NK cells, B cells or activated T cells in the blood.
基于上述说明,本实用新型提供一种保健装置,其至少包含:一低频波发射器、一植物精油载体及一低频波引导体,该植物精油载体设置于该低频波发射器与该低频波引导体之间;其中,该低频波发射器能够发射一预定频率的一低频波,该低频波先穿透该植物精油载体之后,接着往该低频波引导体传递,再接着该低频波的能量集中于该低频波引导体而放出。Based on the above description, the present utility model provides a health care device, which at least includes: a low-frequency wave emitter, a plant essential oil carrier and a low-frequency wave guide. The plant essential oil carrier is arranged between the low-frequency wave emitter and the low-frequency wave guide. between bodies; wherein, the low-frequency wave emitter can emit a low-frequency wave of a predetermined frequency. After the low-frequency wave first penetrates the plant essential oil carrier, it is then transmitted to the low-frequency wave guide body, and then the energy of the low-frequency wave is concentrated. Emitted from the low-frequency wave guide.
于一实施例中,该植物精油载体含有一植物精油。In one embodiment, the plant essential oil carrier contains a plant essential oil.
于一实施例中,该植物精油载体是植物中含有该植物精油的部位,或者是该植物精油装载于容器中,或者是该植物精油吸附于一被吸附物。In one embodiment, the plant essential oil carrier is a part of a plant containing the plant essential oil, or the plant essential oil is loaded in a container, or the plant essential oil is adsorbed on an adsorbed object.
于一实施例中,该预定频率为介于1.27至1.81Hz之间。In one embodiment, the predetermined frequency is between 1.27 and 1.81 Hz.
于一实施例中,该低频波引导体包含一柱体及/或一锥体,该柱体或该锥体设置有一容置空间,该容置空间的内部设置该植物精油载体。In one embodiment, the low-frequency wave guide includes a cylinder and/or a cone, the cylinder or the cone is provided with an accommodating space, and the plant essential oil carrier is disposed inside the accommodating space.
于一实施例中,该保健装置设置于一架体,且位于一使用者的一肚脐的前方而与该肚脐形成一预定距离的一预定位置,该预定距离为介于5至8公分之间。In one embodiment, the health care device is installed on a frame and is located in front of a user's navel and at a predetermined position forming a predetermined distance from the navel. The predetermined distance is between 5 and 8 centimeters. .
于一实施例中,该低频波引导体位于该预定位置。In one embodiment, the low-frequency wave guide is located at the predetermined position.
于一实施例中,该低频波的能量集中于该低频波引导体而放出之后,接着朝向该肚脐发射而抵达该肚脐。In one embodiment, after the energy of the low-frequency wave is concentrated on the low-frequency wave guide and released, it is then emitted toward the navel and reaches the navel.
本实用新型的保健装置及保健方法达到可便利操作、精确辨识使用位置,且非侵入式、非接触式、不会有过度能量风险而造成伤害的保健功效。The health care device and health care method of the present invention achieve the health care effects of being easy to operate, accurately identifying the use position, non-invasive, non-contact, and without the risk of excessive energy causing harm.
附图说明Description of drawings
图1是本实用新型的保健方法于实施时的示意图。Figure 1 is a schematic diagram of the health care method of the present invention during implementation.
图2是本实用新型于执行保健方法时的保健装置的结构示意图。Figure 2 is a schematic structural diagram of the health care device of the present invention when performing the health care method.
图3是本实用新型的保健装置的结构示意图。Figure 3 is a schematic structural diagram of the health care device of the present invention.
图4是本实用新型设置有管路的保健装置的结构示意图。Figure 4 is a schematic structural diagram of the health care device provided with pipelines of the present invention.
图5是本实用新型设置有直立式的棒体的保健装置的结构示意图。Figure 5 is a schematic structural diagram of the health care device provided with an upright rod body of the present invention.
图6是本实用新型的保健装置设置于架体的结构示意图。Figure 6 is a schematic structural diagram of the health care device of the present invention installed on the frame.
图7是本实用新型的保健装置的低频波发射器设置于锥体底面的结构示意图。Figure 7 is a schematic structural diagram of the low-frequency wave transmitter of the health care device of the present invention installed on the bottom surface of the cone.
图号说明:Figure number description:
1:使用者1: User
11:肚脐11: navel
2:低频波发射器2: Low frequency wave transmitter
21:电源21: Power supply
22:振动件22: Vibrating parts
200:架体200: Frame
100:保健装置100: Health care device
3:柱体3: Cylinder
31:柱体顶面31: Top surface of cylinder
32:柱体底面32: Bottom surface of cylinder
33:柱身33: Column body
331:容置空间331: Accommodation space
4:锥体4: Cone
40:顶点40: vertex
401:棒体401: Rod
402:棒体尖端402: Rod tip
41:锥体底面41: Bottom of cone
42:锥身42: Cone body
5:管路5: Pipeline
A:植物精油载体A: Plant essential oil carrier
C:锥体底面中心C: Center of cone bottom
D:预定距离D: Predetermined distance
N:锥体底面法线N: normal to the base of the cone
P:预定位置P: Reserved location
S:虚拟锥体S: virtual cone
S1:虚拟顶点S1: virtual vertex
S2:虚拟底面S2: virtual bottom
W:低频波。W: low frequency wave.
具体实施方式Detailed ways
请参阅图1,本实用新型所提供的一种保健方法,于一使用者1的一肚脐11的前方且与该肚脐11形成一预定距离D的一预定位置P,以一低频波发射器2朝该肚脐11发射一预定频率的一低频波W。前述「前方」指人体的腹部方向的前方并与人体背部所指的「后方」相对应,该预定位置P位于以该肚脐11为一虚拟顶点S1的一虚拟锥体S的一虚拟底面S2上,使得该预定距离D为不大于8公分,或该预定距离为不小于5公分,或该预定距离D为介于5至8公分之间。较佳地,该预定位置P位于该虚拟底面S2的中心,例如该虚拟锥体S为圆锥体且该预定位置P是位于圆形的该虚拟底面S2的圆心且该预定距离D为圆心与该肚脐11的距离其介于5至8公分之间。其中,在该预定位置P与该虚拟顶点S1之间设置一植物精油载体A,该植物精油载体A含有一植物精油,该植物精油指储存于植物中或者由植物所取得在室温下易挥发的油性物质,因此该植物精油载体A可以是植物中含有该植物精油的部位例如是根、茎、叶、花、果实及种子,例如左手香(Plectranthus amboinicus)的叶子,该植物精油载体A也可以是将各种植物经过已知的蒸馏法或萃取法所取得的该植物精油装载于容器中,或者吸附于一被吸附物例如棉花、纸张。该植物精油例如是茶树油、苦炼油、左手香油、柠檬油、冬青油、樟树油、丁香油、薄荷油、桉叶油、香茅油、山鸡椒油、鼠尾草油、尤加利油、玫瑰油、茉莉油、天竺葵油、玫瑰天竺葵油、依兰油、乳香油、广霍香油、迷迭香油、永久花油、百里香油、松树油、雪松油、杜松油、檀香油、萝勒油、莱姆油、桔油、甜橙油、苦橙油、苦橙叶油、橙花油、洋柑橘油、山鸡椒油、牛膝草油、白千层油或姜油。该低频波发射器2朝该肚脐11发射的该低频波W先穿透该植物精油载体A之后,再抵达该肚脐11。Please refer to Figure 1. A health care method provided by the present invention uses a low-frequency wave transmitter 2 at a predetermined position P in front of a navel 11 of a user 1 and forming a predetermined distance D from the navel 11. A low-frequency wave W of a predetermined frequency is emitted toward the navel 11. The aforementioned "front" refers to the front in the direction of the abdomen of the human body and corresponds to the "rear" referred to on the back of the human body. The predetermined position P is located on a virtual base S2 of a virtual cone S with the navel 11 as a virtual vertex S1. , so that the predetermined distance D is no more than 8 centimeters, or the predetermined distance is no less than 5 centimeters, or the predetermined distance D is between 5 and 8 centimeters. Preferably, the predetermined position P is located at the center of the virtual bottom surface S2. For example, the virtual cone S is a cone and the predetermined position P is located at the center of the circular virtual bottom surface S2, and the predetermined distance D is between the center of the circle and the virtual bottom surface S2. The distance between the navel 11 is between 5 and 8 centimeters. Among them, a plant essential oil carrier A is set between the predetermined position P and the virtual vertex S1. The plant essential oil carrier A contains a plant essential oil. The plant essential oil refers to the volatile oil stored in plants or obtained from plants that is easily volatile at room temperature. Oily substances, so the plant essential oil carrier A can be parts of plants containing the plant essential oil, such as roots, stems, leaves, flowers, fruits and seeds, such as leaves of Plectranthus amboinicus. The plant essential oil carrier A can also be The plant essential oils obtained from various plants through known distillation or extraction methods are loaded into a container, or adsorbed on an adsorbed object such as cotton or paper. The plant essential oils include, for example, tea tree oil, bitter oil, lectern oil, lemon oil, wintergreen oil, camphor oil, clove oil, peppermint oil, eucalyptus oil, citronella oil, pheasant oil, sage oil, and eucalyptus oil. Oil, rose oil, jasmine oil, geranium oil, rose geranium oil, ylang-ylang oil, frankincense oil, patchouli oil, rosemary oil, helichrysum oil, thyme oil, pine oil, cedar oil, juniper oil, sandalwood oil, Basil oil, lime oil, tangerine oil, orange oil, bitter orange oil, petitgrain oil, neroli oil, mandarin oil, pheasant oil, hyssop oil, melaleuca oil or ginger oil. The low-frequency wave W emitted by the low-frequency wave transmitter 2 toward the navel 11 first penetrates the plant essential oil carrier A and then reaches the navel 11 .
该低频波发射器2较佳为一低音波换能器,因此该低频波W可以为一低音波,该低音波换能器的结构中包含一电源21及一振动件22,该振动件22与该电源21电性连接,该振动件22为一呈圆盘状的压电陶瓷换能器,该压电陶瓷换能器采用厚度方向极化的压电材料所制成,该电源21提供电力给该振动件22使得该振动件22于厚度方向振动而产生该预定频率的该低音波,其中该预定频率为不大于1.81Hz,或该预定频率为不小于1.27Hz,或该预定频率为介于1.27至1.81Hz之间。最佳地,该预定频率为1.45Hz。The low-frequency wave transmitter 2 is preferably a bass wave transducer, so the low-frequency wave W can be a bass wave. The structure of the bass wave transducer includes a power supply 21 and a vibrating member 22. The vibrating member 22 Electrically connected to the power supply 21, the vibrating element 22 is a disk-shaped piezoelectric ceramic transducer. The piezoelectric ceramic transducer is made of piezoelectric material polarized in the thickness direction. The power supply 21 provides Electric power is supplied to the vibrating member 22 so that the vibrating member 22 vibrates in the thickness direction to generate the bass wave of the predetermined frequency, wherein the predetermined frequency is no more than 1.81 Hz, or the predetermined frequency is no less than 1.27 Hz, or the predetermined frequency is Between 1.27 and 1.81Hz. Optimally, the predetermined frequency is 1.45Hz.
换句话说,本实用新型也提供一种保健装置,该保健装置设置于一使用者1的一肚脐11的前方且与该肚脐11形成一预定距离D的一预定位置P,该保健装置至少包含一低频波发射器2。In other words, the present utility model also provides a health care device, which is arranged in front of a navel 11 of a user 1 and forms a predetermined position P with a predetermined distance D from the navel 11. The health care device at least includes A low frequency wave transmitter 2.
<检测方法及效果一><Detection method and effect 1>
后述表1中的实施例1是对A1人员及A2人员执行前述保健方法,其中该预定距离D为5公分,该预定频率为1.45Hz,该低频波为低音波。A1人员的年龄是74岁,男性;A2人员的年龄是72岁,女性。于执行前述保健方法的前,对A1人员及A2人员抽血取样送交医学检验所进行免疫学检查,检验活化T细胞含量百分比。于执行前述保健方法2小时之后的第19天也同样再次对A1人员抽血取样送交医学检验所进行免疫学检查,而于执行前述保健方法2小时之后的第42天也同样再次对A2人员抽血取样送交医学检验所进行免疫学检查,也是同样检验活化T细胞含量百分比,并将结果记载于后述表一。于表一中的比较例1与实施例1的差别是,比较例1没有使用该植物精油载体A。Example 1 in Table 1 described below is to perform the aforementioned health care method on Person A1 and Person A2, in which the predetermined distance D is 5 cm, the predetermined frequency is 1.45 Hz, and the low-frequency wave is a bass wave. Person A1 is 74 years old and male; Person A2 is 72 years old and female. Before performing the aforementioned health care methods, blood samples from Personnel A1 and Personnel A2 are sent to the Medical Laboratory for immunological examination to test the percentage of activated T cells. On the 19th day after performing the aforementioned health care method for 2 hours, the blood sample of Person A1 was again taken and sent to the Medical Laboratory for immunological examination. On the 42nd day after 2 hours of performing the aforementioned health care method, Personnel A2 was also sampled again. Blood samples were taken and sent to the Medical Laboratory for immunological examination. The percentage of activated T cells was also tested, and the results were recorded in Table 1 below. The difference between Comparative Example 1 and Example 1 in Table 1 is that Comparative Example 1 does not use the plant essential oil carrier A.
表1Table 1
从表1可以得知,A1人员于“没有”使用植物精油载体的比较例1其活化T细胞含量变化率为206.5%,于“有”使用植物精油载体的实施例1其活化T细胞含量变化率为234.8%,也就是有使用植物精油载体的前述保健方法可以使得活化T细胞含量更增加28.3%。A2人员于“没有”使用植物精油载体的比较例1其活化T细胞含量变化率为149%,于“有”使用植物精油载体的实施例1其活化T细胞含量变化率为180%,也就是有使用植物精油载体的前述保健方法可以使得活化T细胞含量更增加31%。显然地,本实用新型的保健方法深具有效且可以维持长久的保健功效。It can be seen from Table 1 that the change rate of activated T cell content in Comparative Example 1 "without" using plant essential oil carrier by A1 was 206.5%, and the change rate of activated T cell content in Example 1 "with" using plant essential oil carrier The rate is 234.8%, which means that the aforementioned health care method using plant essential oil carriers can increase the content of activated T cells by 28.3%. In Comparative Example 1 without the use of plant essential oil carriers, the change rate of activated T cell content by A2 personnel was 149%, and in Example 1 with plant essential oil carriers, the change rate of activated T cell content was 180%, that is The aforementioned health care method using plant essential oil carriers can increase the content of activated T cells by 31%. Obviously, the health care method of the present invention is highly effective and can maintain long-term health care effects.
<检测方法及效果二><Detection method and effect 2>
后述表2中的实施例2、3、4及5是分别对A3、A4、A5及A6人员执行前述保健方法,其中该预定距离D为5公分,该预定频率为1.45Hz,该低频波为低音波。A3人员的年龄是67岁男性,A4人员的年龄是64岁男性,A5人员的年龄是73岁女性,A6人员的年龄是47岁女性。于执行前述保健方法之前,分别对A3、A4、A5及A6人员抽血取样送交医学检验所进行免疫学检查,以检验NAD+浓度其单位为nanomoles per liter(nmol/L)。进行前述保健方法2小时之后的第19天也同样再次分别对A3、A4、A5及A6人员抽血取样送交医学检验所进行免疫学检查,也是同样检验NAD+浓度。将结果记载于后述表2。Embodiments 2, 3, 4 and 5 in the following Table 2 respectively perform the aforementioned health care method on persons A3, A4, A5 and A6, in which the predetermined distance D is 5 cm, the predetermined frequency is 1.45Hz, and the low-frequency wave For bass waves. Person A3 is a 67-year-old male, Person A4 is a 64-year-old male, Person A5 is a 73-year-old female, and Person A6 is a 47-year-old female. Before implementing the aforementioned health care methods, blood samples from personnel A3, A4, A5 and A6 were taken and sent to the Medical Laboratory for immunological examination to test the NAD + concentration, the unit of which is nanomoles per liter (nmol/L). On the 19th day after performing the aforementioned health care method for 2 hours, blood samples were taken again from personnel A3, A4, A5 and A6 and sent to the Medical Laboratory for immunological examination, and the NAD + concentration was also tested in the same way. The results are listed in Table 2 described below.
表2Table 2
从表2可以得知,A3人员于执行前述保健方法之前的NAD+浓度为43nmol/L,于执行前述保健方法之后的NAD+浓度为116nmol/L,变化率为270%,也就是NAD+浓度增加了160%。类似地,A4人员于执行前述保健方法之前的NAD+浓度为26nmol/L,于执行前述保健方法之后的NAD+浓度为64nmol/L,变化率为246%,也就是NAD+浓度增加了146%。A5人员于执行前述保健方法之前的NAD+浓度为23nmol/L,于执行前述保健方法之后的NAD+浓度为42nmol/L,变化率为183%,也就是NAD+浓度增加了83%。A6人员于执行前述保健方法之前的NAD+浓度为32nmol/L,于执行前述保健方法之后的NAD+浓度为53nmol/L,变化率为166%,也就是NAD+浓度增加了66%。因此,本实用新型所提供的一种保健方法可以促使NAD+浓度增生,且只要单次执行2小时就可以使得NAD+浓度增加,显然地,本实用新型的保健方法深具有效且可以维持长久的保健功效。It can be seen from Table 2 that the NAD + concentration of Person A3 before performing the aforementioned health care method was 43 nmol/L, and the NAD + concentration after performing the aforementioned health care method was 116 nmol/L, with a change rate of 270%, that is, the NAD + concentration An increase of 160%. Similarly, the NAD + concentration of Person A4 before performing the aforementioned health care method was 26 nmol/L, and the NAD + concentration after performing the aforementioned health care method was 64 nmol/L, with a change rate of 246%, that is, the NAD + concentration increased by 146%. . The NAD + concentration of person A5 before performing the aforementioned health care method was 23 nmol/L, and the NAD + concentration after performing the aforementioned health care method was 42 nmol/L. The change rate was 183%, that is, the NAD + concentration increased by 83%. The NAD + concentration of person A6 before performing the aforementioned health care method was 32 nmol/L, and the NAD + concentration after performing the aforementioned health care method was 53 nmol/L. The change rate was 166%, that is, the NAD + concentration increased by 66%. Therefore, the health care method provided by the present utility model can promote the proliferation of NAD + concentration, and can increase the NAD + concentration as long as it is performed for 2 hours. Obviously, the health care method of the present utility model is highly effective and can be maintained for a long time. health benefits.
请参阅图2及图3,本实用新型又提供一种可用以执行前述保健方法的保健装置100,该保健装置100包含:前述该低频波发射器2、一柱体3及一锥体4。该柱体3较佳为圆柱体,该柱体具有一柱体顶面31、一柱体底面32及两端分别与该柱体顶面31及该柱体底面32相接的一柱身33,其中该柱身33设置有自该柱体底面32往该柱体顶面31方向凹陷的一容置空间331,该容置空间331的内部设置该植物精油载体A。该锥体4具有一顶点40、一锥体底面41及两端分别与该顶点40及该锥体底面41相接的一锥身42。其中,该柱体顶面31与该锥体底面41对应相接合例如以焊接或螺丝锁固。较佳地,该柱体3及该锥体4分别为金属柱体及金属锥体。更佳地,该柱体3及该锥体4为一体成型,换句话说,该柱体顶面31、该柱身33、该锥身42及该顶点40为一体成型。特别说明的是,上述该柱体3及该锥体4组合后合称为一低频波引导体。Please refer to Figures 2 and 3. The present invention also provides a health care device 100 that can be used to perform the aforementioned health care method. The health care device 100 includes: the aforementioned low-frequency wave transmitter 2, a cylinder 3 and a cone 4. The cylinder 3 is preferably a cylinder, and the cylinder has a cylinder top surface 31, a cylinder bottom surface 32 and a cylinder body 33 with both ends connected to the cylinder top surface 31 and the cylinder bottom surface 32 respectively. , wherein the column body 33 is provided with an accommodating space 331 that is recessed from the column bottom surface 32 toward the column top surface 31 , and the plant essential oil carrier A is disposed inside the accommodating space 331 . The cone 4 has a vertex 40, a cone bottom 41 and a cone body 42 with two ends connected to the vertex 40 and the cone bottom 41 respectively. The top surface 31 of the cylinder and the bottom surface 41 of the cone are connected correspondingly, for example, by welding or screwing. Preferably, the cylinder 3 and the cone 4 are metal cylinders and metal cones respectively. More preferably, the cylinder 3 and the cone 4 are integrally formed. In other words, the cylinder top surface 31, the cylinder body 33, the cone body 42 and the apex 40 are integrally formed. It should be noted that the combination of the above-mentioned cylinder 3 and the cone 4 is collectively called a low-frequency wave guide body.
该低频波发射器2与该柱体底面32相连接,较佳地该低频波发射器2与该柱体底面32直接相连接,例如该低频波发射器2焊接或以螺丝锁固于该柱体底面32,因此当启动该电源21后会使得该振动件22产生该预定频率的该低频波W(请再度参阅图1)。接着,该低频波W传递至该柱体底面32并穿透该植物精油载体A之后,再接着利用该柱身33依序往该锥体4的该锥体底面41及该顶点40传递,并利用该锥体4由该锥体底面41的较宽而往该顶点40的较窄而成形为锥形的设计,而使该低频波W越往该顶点40传递时其能量越形聚集。因此,当该低频波W传递至该顶点40时,该低频波W其能量聚集到最大,且从该顶点40朝该肚脐11发射;由于该锥体4的该顶点40为一尖端,因此该低频波W可以形成类似电学中的「尖端放电」的原理而将该低频波W的能量集中于该顶点40而放出并且朝向该肚脐11发射而抵达该肚脐11。特别说明的是,此时该顶点40是位于该预定位置P。The low-frequency wave transmitter 2 is connected to the bottom surface 32 of the column. Preferably, the low-frequency wave transmitter 2 is directly connected to the bottom surface 32 of the column. For example, the low-frequency wave transmitter 2 is welded or screwed to the column. Therefore, when the power supply 21 is turned on, the vibrating member 22 will generate the low-frequency wave W of the predetermined frequency (please refer to FIG. 1 again). Then, after the low-frequency wave W is transmitted to the bottom surface 32 of the cylinder and penetrates the plant essential oil carrier A, the low-frequency wave W is then transmitted to the cone bottom surface 41 and the vertex 40 of the cone 4 sequentially using the cylinder 33, and Utilizing the design that the cone 4 is shaped into a cone from being wider at the bottom surface 41 of the cone to being narrower toward the apex 40 , the energy of the low-frequency wave W becomes more concentrated as it propagates toward the apex 40 . Therefore, when the low-frequency wave W is transmitted to the vertex 40, the energy of the low-frequency wave W is concentrated to the maximum and is emitted from the vertex 40 toward the navel 11; since the vertex 40 of the cone 4 is a tip, the The low-frequency wave W can form a principle similar to the "tip discharge" in electricity to concentrate the energy of the low-frequency wave W on the vertex 40 and emit it toward the navel 11 to reach the navel 11 . It should be noted that at this time, the vertex 40 is located at the predetermined position P.
请参阅图4,于另一实施例中,该低频波发射器2以一管路5与该柱体底面32及该容置空间331相连接,该低频波W借由该管路5而从该低频波发射器2传递至该柱体底面32及该容置空间331,接着如前所述穿透该植物精油载体A之后传递至该顶点40并朝该肚脐11发射而抵达该肚脐11。利用该管路5的设置可以使得该低频波发射器2的该电源21及/或该振动件22远离人体,以避免已经植入人体内部的电子装置受到干扰。Please refer to Figure 4. In another embodiment, the low-frequency wave transmitter 2 is connected to the bottom surface 32 of the column and the accommodation space 331 through a pipeline 5, and the low-frequency wave W is emitted from the pipeline 5. The low-frequency wave emitter 2 is transmitted to the bottom surface 32 of the cylinder and the accommodating space 331 , and then penetrates the plant essential oil carrier A as described above, and then is transmitted to the vertex 40 and emitted toward the navel 11 to reach the navel 11 . The arrangement of the pipeline 5 can keep the power supply 21 and/or the vibrator 22 of the low-frequency wave transmitter 2 away from the human body to avoid interference with electronic devices that have been implanted in the human body.
请参阅图5,于另一实施例中,在该顶点40还设置有朝向远离该锥体底面41的方向的一呈直立式的棒体401,较佳地该棒体401为金属棒体例如金属丝或线,且该棒体401的长度方向与通过该锥体底面41的锥体底面中心C的锥体底面法线N重合并朝向该肚脐11。因此,可以更引导该低频波W的能量集中于该棒体401的一棒体尖端402而放出并且朝向该肚脐11发射。特别说明的是,此时该棒体尖端402是位于该预定位置P。Please refer to Figure 5. In another embodiment, the vertex 40 is also provided with an upright rod 401 facing away from the cone bottom 41. Preferably, the rod 401 is a metal rod, such as The length direction of the rod 401 coincides with the cone bottom normal N passing through the cone bottom center C of the cone bottom 41 and faces the navel 11 . Therefore, the energy of the low-frequency wave W can be directed to be concentrated on a rod tip 402 of the rod 401 and emitted toward the navel 11 . It should be noted that at this time, the rod tip 402 is located at the predetermined position P.
请参阅图6,于另一实施例中,该保健装置100设置于一架体200,使用者1平躺于平台上(图未绘出),该架体200架设于平台上,该保健装置100位于使用者的肚脐上方。如此,使用者于保健过程也可以获得适当地休息。Please refer to Figure 6. In another embodiment, the health care device 100 is installed on a frame 200. The user 1 lies flat on the platform (not shown). The frame 200 is set up on the platform. The health care device 100 is located above the user's belly button. In this way, users can also get proper rest during the health care process.
请参阅图7,于另一实施例中,该保健装置100也可以是包含:前述该低频波发射器2及该锥体4,而不包含该柱体3,其中该锥身42设置有自该锥体底面41往该顶点40方向凹陷的该容置空间331,该容置空间331的内部设置该植物精油载体A。特别说明的是,此时该锥体4为该低频波引导体,而不包含该柱体3。该低频波发射器2设置于该锥体底面41,该低频波发射器2与该锥体底面41相连接,较佳地该低频波发射器2与该锥体底面41直接相连接,例如该低频波发射器2以黏着、焊接或以螺丝锁固于该锥体底面41,因此当启动该电源21后会使得该振动件22产生该预定频率的该低频波W(请再度参阅图1)。接着,该低频波W传递至该锥体4的该锥体底面41并穿透该植物精油载体A之后往该顶点40传递,并利用该锥体4由该锥体底面41的较宽而往该顶点40的较窄而成形为锥形的设计,而使该低频波W越往该顶点40传递时其能量越形聚集。较佳地,该锥体4为一体成型的木制锥体。Please refer to Figure 7. In another embodiment, the health care device 100 may also include: the aforementioned low-frequency wave transmitter 2 and the cone 4 instead of the cylinder 3, wherein the cone 42 is provided with an automatic The bottom surface 41 of the cone is recessed toward the apex 40 of the accommodating space 331, and the plant essential oil carrier A is disposed inside the accommodating space 331. It should be noted that at this time, the cone 4 is a low-frequency wave guide body and does not include the cylinder 3 . The low-frequency wave transmitter 2 is disposed on the cone bottom 41, and the low-frequency wave transmitter 2 is connected to the cone bottom 41. Preferably, the low-frequency wave transmitter 2 is directly connected to the cone bottom 41, such as the The low-frequency wave transmitter 2 is adhered, welded or screwed to the bottom surface 41 of the cone, so that when the power supply 21 is turned on, the vibrating member 22 will generate the low-frequency wave W of the predetermined frequency (please refer to Figure 1 again) . Then, the low-frequency wave W is transmitted to the cone bottom 41 of the cone 4 and penetrates the plant essential oil carrier A and then is transmitted to the vertex 40 and uses the cone 4 to travel from the wider cone bottom 41 to The narrower and tapered design of the vertex 40 causes the energy of the low-frequency wave W to accumulate more and more as it propagates toward the vertex 40 . Preferably, the cone 4 is an integrally formed wooden cone.
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW112203278U TWM643521U (en) | 2023-04-11 | 2023-04-11 | health care device |
TW112203278 | 2023-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN220193829U true CN220193829U (en) | 2023-12-19 |
Family
ID=88148280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202320828367.7U Active CN220193829U (en) | 2023-04-11 | 2023-04-14 | Health care device |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN220193829U (en) |
TW (1) | TWM643521U (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI832746B (en) * | 2023-04-11 | 2024-02-11 | 李洲科技股份有限公司 | health device |
-
2023
- 2023-04-11 TW TW112203278U patent/TWM643521U/en unknown
- 2023-04-14 CN CN202320828367.7U patent/CN220193829U/en active Active
Also Published As
Publication number | Publication date |
---|---|
TWM643521U (en) | 2023-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN217661124U (en) | Health care device | |
US11478656B2 (en) | Apparatus for systemic human enhancement from administration of frequency therapy including enhanced stem cell and genetic therapy and methods for using same | |
US20150209564A1 (en) | Ultrasound device and therapeutic methods | |
CN101443074A (en) | Integrated coil device and method for using the same | |
CN220193829U (en) | Health care device | |
CN103830850A (en) | Multichannel ultrasonic acupuncture point stimulation method and device | |
Zou et al. | A fully integrated conformal wearable ultrasound patch for continuous sonodynamic therapy | |
US20160339261A1 (en) | Medical Bioelectric Plasma Beam | |
TWM628886U (en) | Health-care device | |
TWI832746B (en) | health device | |
TWM638574U (en) | Healthcare apparatus | |
CN219049394U (en) | health care device | |
TWI820960B (en) | health care methods | |
CN117919072A (en) | Health care device and health care method | |
CN102666832A (en) | Device for modulating PGC-1 expression, and treating device and treating method for ischemic disease | |
TWI851462B (en) | Health care devices | |
TWI824937B (en) | health device | |
TWI814328B (en) | health care device | |
WO2015041254A1 (en) | Device for treating vascular endothelial dysfunction, method for treating vascular endothelial dysfunction, and activation control method for plcγ1, erk5 or erk1/2 | |
CN116920281A (en) | Health care device and health care method | |
Mohammadi Jahromi | Investigating the potential of using low-intensity ultrasound on skin cells for facial skin cancer treatment | |
Hydroliposuction | Surgical Treatment | |
Akyel | Services to Operate and Maintain a Microwave Research Laboratory. | |
KR20070015908A (en) | Electromagnetic therapy apparatus and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |